Clinical trial
Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With…
NCT00469417 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00469417 |
|---|---|
| Title | Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma |
| Official title | A Multicenter, Phase III, Randomised Study of Photodynamic Therapy With Metvix Cream 160 mg/g in Comparison With Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Superficial Basal Cell Carcinoma |
| Intervention type | Drug, Procedure |
| Interventions | Metvix® cream, Hand held liquid nitrogen spray cryotherapy |
| Enrollment | 120 |
| Start date | Oct 18, 1999 |
| Primary completion | Sep 5, 2001 |
| Completion | Apr 1, 2005 |
| First posted | May 4, 2007 |
| Last update posted | Aug 19, 2024 |
| Countries | Austria, Belgium, Finland, France, Italy, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: